PAX Financial Group’s Surgery Partners SGRY Stock Holding History

PAX Financial Group’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,609	Closed	-$457K	–	246
2023 Q3	$457K	Buy	+15,609	New	+$561K	0.1%	160

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAX Financial Group's SGRY Position: Q4 2023 in Review

PAX Financial Group sold out of Surgery Partners (SGRY) in Q4 2023, closing a stake of 15,609 shares — an estimated $457K sold.

PAX Financial Group first reported a position in SGRY in Q3 2023 and held it in 1 quarter. The position peaked at $457K in Q3 2023. 174 funds tracked by Wall St. Rank hold SGRY as of Q4 2023.

PAX Financial Group reported no remaining Surgery Partners position as of Q4 2023 after selling out during the quarter.
PAX Financial Group sold 15,609 Surgery Partners shares in Q4 2023, an estimated $457K.
PAX Financial Group first reported a position in Surgery Partners in Q3 2023 and held it in 1 quarter.
PAX Financial Group's Surgery Partners position peaked at $457K in Q3 2023.
174 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2023.

Based on PAX Financial Group's 13F filing for Q4 2023, filed 12 Feb 2024.